Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02200614
Title Efficacy and Safety Study of ODM-201 in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer
Acronym ARAMIS
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Orion Corporation, Orion Pharma
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | SWE | SVK | ROU | POL | LVA | LTU | ITA | ISR | HUN | GBR | FRA | FIN | EST | ESP | DEU | CZE | CAN | BRA | BGR | BEL | AUT | AUS | ARG


No variant requirements are available.